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Influenza pandemics are often perceived as single-
year events, but the burden of previous influenza pan-
demics has in reality been spread over a number of 
years. The aim of this paper is to compare the burden 
of influenza in the pandemic year 2009/10 with that 
in the year immediately after (2010/11) in England. 
We compared four measures of disease. There was a 
greater burden of severe illness in 2010/11 compared 
with 2009/10: more deaths (474 vs 361), more criti-
cal care admissions (2,200 vs 1,700), and more hos-
pital admissions (8,797 vs 7,879). In contrast, there 
were fewer general practice consultations in 2010/11 
compared with 2009/10 (370,000 vs 580,000). There 
was also much less public interest in influenza, as 
assessed by number of Google searches. This is a 
worrying finding, as by the time of the second influ-
enza season, much had been learnt about the poten-
tial impact of the influenza A(H1N1)pdm09 virus and 
an effective vaccine developed. We suggest that a 
widespread assumption of ‘mildness’ led to insuffi-
cient ongoing action to prevent influenza and hence to 
avoidable influenza-related deaths. This offers a les-
son to all countries, both for future influenza seasons 
and for pandemic preparedness planning.
Introduction
The	 public	 perception	 of	 influenza	 pandemics	 tends	
to	 be	 as	 single-year	 events.	 Contingency	 plans	 also	
assume	that	a	new	virus	emerges	and	sweeps	through	
the	population,	causing	infection	and	death	over	a	sin-
gle	year	 [1-4].	History,	however,	 tells	a	different	story.	
Previous	 pandemics	 have	 involved	 waves	 over	 multi-
ple	 years,	 each	 causing	pronounced	mortality	 [1].	 The	
1968/69	pandemic	was	described	as	the	‘smouldering	
pandemic’.	 In	 England	 and	 other	 European	 countries,	
its	burden	was	greater	in	the	1969/70	influenza	season	
than	in	the	1968/69	season	[5].	
When	 illness	 associated	 with	 the	 influenza	 A(H1N1)
pdm09	virus	(initially	dubbed	‘swine	flu’)	was	detected	
in	 April	 2009,	 the	 public	 health	 response	 in	 England	
was	 intensive.	 In	 an	 initial	 containment	 phase,	 all	
contacts	 of	 cases	 were	 identified	 and	 treated	 with	
antiviral	medication,	 to	minimise	 spread	 of	 the	 virus.	
Schools	were	closed	or	partially	closed.	When	increas-
ing	 levels	 of	 influenza	 put	 serious	 pressure	 on	 the	
capacity	 of	 general	 practices	 to	 cope,	 a	 novel	 tel-
ephone	 and	 Internet-based	 system	was	 introduced	 to	
mitigate	 this.	 This	 system,	 the	National	 Pandemic	 Flu	
Service,	ensured	the	public	had	ready	access	to	antivi-
rals.	 A	widespread	 social	marketing	 campaign,	 ’Catch	
it.	Bin	it.	Kill	it’,	emphasised	the	importance	of	hygiene	
measures	 (cough	 etiquette,	 hand	 washing)	 [6].	 The	
pandemic	also	received	extensive	media	coverage.	
Fortunately	 the	 virus,	 and	 the	 pandemic,	 was	 milder	
than	 many	 had	 initially	 feared.	 Some	 criticised	 the	
government	 measures	 in	 the	 United	 Kingdom	 as	 a	
costly	 overreaction	 [7,8],	 though	a	 formal	 inquiry	 into	
the	 management	 of	 the	 pandemic	 called	 the	 overall	
response	‘highly	satisfactory’	[9].
In	contrast,	 in	the	year	after	the	pandemic,	early	com-
ments	 from	 both	 from	 the	 Health	 Protection	 Agency	
and	 Department	 of	 Health	 were	 generally	 reassur-
ing	about	 the	 likely	 impact	of	 influenza	 in	 the	coming	
weeks	[10,11].	The	usual	national	advertising	campaign	
to	promote	the	seasonal	influenza	vaccine	was	not	run	
[12].	When	the	number	of	severe	cases	rose	and	there	
were	 influenza-related	 deaths,	 the	 government	 was	
consequently	criticised	for	complacency	[13].
This	 study	 uses	 a	 number	 of	 objective	 measures	 to	
assess	 how	 the	 burden	 of	 influenza	A(H1N1)pdm09	 in	
the	year	after	the	pandemic	compared	with	that	in	the	
pandemic	year	itself.
Methods
Using	 published	 sources,	we	 compared	 the	 burden	 of	
influenza	 in	 the	 pandemic	 year	 (2009/10)	with	 that	 in	
the	 following	 year	 (2010/11)	 using	 four	measures	 that	
were	replicable	across	the	two	years.	We	also	assessed	
public	interest	in	influenza	and	antiviral	usage	over	the	
same	time	period.
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General practice consultations
The	Royal	College	of	General	Practitioners	 (RCGP)	has	
undertaken	 surveillance	 of	 influenza-like	 illness	 (ILI)	
(clinically	defined)	in	general	practice	for	over	40	years.	
The	system	uses	around	100	sentinel	general	practices	
across	England,	covering	a	population	of	approximately	
800,000.	 The	 system	 extracts	 summary	 information	
(based	on	read	codes	[14])	 from	general	practice	elec-
tronic	 records.	 This	 is	 used	 to	 estimate	 the	 rate	of	 ILI	
consultations	in	the	population	of	England	as	a	whole.	
These	 estimates,	 by	 age	 and	 week	 of	 consultation,	
were	 supplied	 by	 the	 RCGP	 Research	 &	 Surveillance	
Centre.	We	used	 these,	 together	with	mid-2009	popu-
lation	estimates	from	the	Office	for	National	Statistics	
[15],	to	estimate	the	total	number	of	ILI	consultations	in	
England	in	each	year.
Hospital admissions
Information	on	hospital	admissions	was	extracted	from	
Hospital	 Episode	 Statistics	 (HES)	 [16].	 This	 database	
contains	 details	 of	 all	 admissions	 to	 National	 Health	
Service	 (NHS)	hospitals	 in	England.	Admission	details	
are	coded	 locally	and	uploaded	to	a	central	database.	
Two	 particular	 codes	 are	 used	 for	 influenza-related	
admissions:	 International	 Classification	 of	 Diseases	
(ICD)	 codes	 J10:	 influenza	 due	 to	 other	 identified	
influenza	 virus	 or	 J11:	 influenza,	 virus	 not	 identified).	
Instances	of	these	codes	were	extracted	by	age	and	by	
week	of	hospital	admission.	
Intensive care admissions
During	 the	pandemic	and	 the	 following	year,	 all	 acute	
NHS	hospitals	 reported	 both	 influenza-related	 critical	
care	bed	occupancy	data	(in	‘bed-days’)	and	the	number	
of	critical-care	beds	occupied	at	8	a.m.	on	Wednesday	
mornings	 by	 age	 group	 to	 the	 Department	 of	 Health.	
These	 data	 recorded	 both	 suspected	 and	 confirmed	
cases	 of	 influenza.	 Suspected	 cases	 were	 those	 who	
were	being	 treated	 for	 influenza	on	 the	basis	 of	 clini-
cal	 suspicion	 but	 awaiting	 laboratory	 microbiological	
confirmation.	Confirmed	cases	were	those	in	whom	the	
diagnosis	had	been	confirmed	by	a	specific	microbio-
logical	test.	
A	 national	 surveillance	 system	 in	 the	 pandemic	 year	
calculated	the	mean	influenza-related	length	of	stay	in	
critical	care	as	seven	days	[17].	We	therefore	estimated	
the	 number	 of	 admissions	 to	 critical	 care	 by	 dividing	
the	 total	 number	 of	 reported	 critical	 care	 bed	 days	
by	 seven.	 Critical	 care	 bed	 occupancy	 data	were	 only	
recorded	 from	 12	 July	 2009	 to	 21	 February	 2010	 and	
from	20	December	2010	to	20	January	2011.	
Deaths
During	 the	 pandemic	 year,	 a	 special	 reporting	 sys-
tem	 provided	 details	 of	 influenza-related	 deaths	 to	
England’s	 Chief	 Medical	 Officer	 [18-20].	 Deaths	 were	
considered	 influenza-related	 if	 the	 virus	 had	 been	
laboratory-confirmed,	if	influenza	was	recorded	on	the	
death	 certificate,	 or	 both.	 During	 the	 following	 year,	
the	Health	Protection	Agency	ran	a	similar	system.	 Its	
definition	 of	 an	 influenza-related	 death	 was	 slightly	
narrower,	 requiring	 both	 laboratory	 confirmation	 and	
the	recording	of	influenza	on	the	death	certificate	[21].	
Public interest in influenza
A	proxy	chosen	for	public	awareness	of	–	and	interest	
in	 –	 influenza	 was	 Google	 data	 on	 the	 rate	 at	 which	
particular	search	terms	were	used	in	its	Internet	search	
engine.	 We	 downloaded	 data	 describing	 the	 volume	
of	 searches	 for	 the	 term	 ‘flu’	 by	 week	 in	 the	 United	
Kingdom.	 The	 absolute	 number	 of	 searches	 was	 not	
made	available,	thus	the	data	describe	the	relative	vol-
ume	between	weeks.
Defining the influenza season
In	 England,	 the	 influenza	 season	 runs	 from	 the	 start	
of	October	to	the	start	of	April,	with	peak	activity	typi-
cally	 in	 December	 and	 January	 [22].	 As	 the	 pandemic	
virus	 circulated	 outside	 the	 usual	 influenza	 season,	
however,	 we	 defined	 the	 pandemic	 year	 as	 starting	
when	general	practice	consultations	due	to	ILI	first	rose	
above	30	per	100,000	people	per	week,	 the	 threshold	
for	normal	seasonal	 influenza	activity.	 In	 the	year	 fol-
lowing	 the	 pandemic,	 we	 defined	 the	 start	 as	 being	
the	usual	start	of	an	influenza	season,	i.e.	the	start	of	
October.	For	both	years,	we	defined	the	season	end	as	
the	 end	 of	 February.	 Thus	 the	 two	 seasons	 analysed	
were	29 June	2009	to	28	February	2010	(pandemic	year)	
and	4	October	2010	to	27	February	2011	(second	year).	
Antiviral prescribing data
Data	 describing	 the	 number	 of	 antiviral	 medication	
(oseltamivir	and	zanamivir)	courses	dispensed	by	phar-
macists	in	the	community	in	England	were	provided	by	
the	NHS	Business	Services	Authority.	 Equivalent	 data	
were	published	by	 the	National	Pandemic	Flu	Service,	
describing	 the	 number	 of	 courses	 dispensed	 through	
this	service,	which	was	established	specifically	for	the	
pandemic.	Data	 on	 the	number	 of	 courses	of	 antiviral	
medication	 (oseltamivir	 or	 zanamivir)	 dispensed	 were	
published	by	the	National	Pandemic	Flu	Service.
Oseltamivir	 and	zanamivir	 are	prescription-only	medi-
cations.	An	electronic	 record	of	all	prescriptions	proc-
essed	by	community	pharmacists	is	sent	to	the	central	
NHS	Prescription	Services,	in	order	for	the	pharmacist	
to	 receive	 reimbursement.	 These	 data	 are	 pooled	 to	
produce	the	total	number	of	prescriptions	of	each	dis-
crete	pharmaceutical	item	listed	in	the	British	National	
Formulary	 [23].	 Although	 the	 data	 do	 not	 include	 pri-
vate	prescriptions,	by	including	all	prescriptions	issued	
by	 the	NHS,	 they	will	 include	 the	vast	majority	of	pre-
scriptions	issued	in	the	community	in	England.
Results
Three	distinct	waves	of	influenza	activity	occurred	dur-
ing	 the	 two-year	 period	 (Figures	 1	 and	 2):	 two	 during	
the	pandemic	year	 (2009/10)	and	a	single	wave	 in	 the	
second	year	(2010/11).	
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Figure 1
Influenza-related general practice consultations and hospital admissions, England, 5 January 2009–13 March 2011
GP:	general	practice.
0
500
1,000
1,500
2,000
2,500
3,000
3,500
4,000
4,500
0
20
40
60
80
100
120
140
160
180
Ja
n
Fe
b
M
ar Ap
r
M
ay Ju
n Ju
l
Au
g
Se
p
O
ct
No
v
De
c
Ja
n
Fe
b
M
ar Ap
r
M
ay Ju
n Ju
l
Au
g
Se
p
O
ct
No
v
De
c
Ja
n
Fe
b
M
ar
W
ee
kl
y 
nu
m
be
r o
f h
os
pi
ta
l a
dm
is
ss
io
ns
 
W
ee
kl
y 
GP
 c
on
su
lta
tio
n 
ra
te
 
(n
um
be
r p
er
 10
0,
00
0 
pe
rs
on
s)
Date (month, year)
2009 2010 2011
Hospital admissions
GP consultations
Figure 2
Influenza-related critical care admissions and deaths, England, 15 June 2009–13 March 2011
0
100
200
300
400
500
600
700
800
0
30
60
90
120
150
180
210
Ju
n Ju
l
Au
g
Se
p
O
ct
No
v
De
c
Ja
n
Fe
b
M
ar Ap
r
M
ay Ju
n Ju
l
Au
g
Se
p
O
ct
No
v
De
c
Ja
n
Fe
b
M
ar
W
ee
kl
y 
nu
m
be
r o
f c
rit
ic
al
 c
ar
e 
be
ds
 o
cc
up
pi
ed
W
ee
kl
y 
nu
m
be
 o
f d
ea
tth
s
Deaths
Critical care
Date (month, year)
2009 2010 2011
4 www.eurosurveillance.org
The	first	wave	occurred	in	July	and	August	2009,	peak-
ing	 12	weeks	 after	 the	 first	 case	 of	 influenza	 A(H1N1)
pdm09	was	 reported	 in	 England.	 This	wave	was	 char-
acterised	 by	 a	 short	 sharp	 rise	 and	 fall	 in	 influenza	
activity,	as	assessed	both	by	general	practice	consul-
tations	and	hospital	admissions.	
The	second	wave	occurred	in	autumn	2009.	There	was	
a	gradual	and	prolonged	rise	 in	 influenza	activity	that	
lasted	for	several	weeks.	Assessed	by	general	practice	
consultations,	the	incidence	of	influenza	in	the	commu-
nity	was	lower	than	in	the	first	wave.	However,	rates	of	
influenza	 activity	 in	 hospital	 were	much	 greater	 than	
those	in	the	first	wave.	
The	third	wave	occurred	in	December	2010	and	January	
2011	and	was	characterised	by	a	short	sharp	 rise	and	
fall	in	influenza	activity.	This	wave	was	associated	with	
greater	peaks	 in	hospital	 and	critical	 care	admissions	
than	either	of	the	previous	two	waves.
Overall,	 the	 burden	 of	 severe	 illness	 caused	 by	 influ-
enza	 (deaths,	 critical	 care	 and	 hospital	 admissions)	
was	greater	in	the	second	year	than	the	pandemic	year	
(Table	1).	There	were	approximately	10%	more	hospital	
admissions,	 30%	more	 deaths	 and	 30%	more	 critical	
care	admissions	in	the	second	year	than	in	both	waves	
of	 the	pandemic	year	 combined.	 The	 reverse	was	 true	
for	general	practice	consultations:	there	were	approxi-
mately	35%	 fewer	of	 these	 in	 the	second	year	 than	 in	
the	pandemic	year.	
Influenza	activity	in	the	second	year	was	concentrated	
far	more	intensively	than	in	the	pandemic	year.	Most	of	
the	activity	was	concentrated	in	an	eight-week	period.	
The	 busiest	 four	 weeks	 in	 the	 second	 year	 involved	
three	 times	as	many	hospital	 admissions	as	 the	busi-
est	 four	 weeks	 in	 the	 pandemic	 year	 (20	 December	
2010	 to	 16	 January	 2011:	 1,643	 admissions	 per	 week;	
2  November	 2009	 to	 30	 November	 2009:	 510	 admis-
sions	per	week).	Similarly,	there	were	over	three	times	
as	 many	 critical	 care	 admissions	 per	 week	 over	 the	
same	 periods	 (mean	 critical	 care	 bed	 occupancy:	 661	
vs	 170).	 The	 peak	 weekly	 hospital	 admission	 rate	 in	
the	second	year	was	more	than	three	times	that	of	the	
pandemic	 year	 (week	 ending	 2	 January	 2011:	 2,334	
admissions;	week	ending	3	October	2009:	604	admis-
sions).	The	peak	critical	care	bed	occupancy	in	the	sec-
ond	year	was	four	times	that	of	the	pandemic	year	(851	
beds	on	4	 January	2011,	compared	with	a	peak	of	 196	
in	November	2009).
Table 1
Influenza-related general practice consultations, hospital 
admissions, critical care admissions and deaths, England, 
pandemic year 2009/10 and second year 2010/11a  
Type of influenza-related 
event
Number of events
Pandemic year
2009/10a
Second year 
2010/11a
Number	of	general	practice	
consultations	 580,000 370,000
Number	of	hospital	
admissions	 7,879 8,797
Number	of	critical	care	
admissions 1,700 2,200
Number	of	deaths	 361 474b	(436)
a	 Pandemic	year:	29	June	2009	to	28	February	2010.	
Second	year:	4	October	2010	to	27	February	2011.
b	 Deaths	reported	by	the	Health	Protection	Agency	from	4	October	
2010	to	4	May	2011.	The	number	in	parentheses	is	the	estimated	
number	of	deaths	due	to	influenza	A(H1N1),	based	on	91.9%	
of	all	influenza-related	deaths	in	the	United	Kingdom	being	
attributable	to	influenza	A(H1N1)	[21].
Table 2
The age distribution of influenza-related general practice consultations, hospital admissions, critical care admissions and 
deaths, England, pandemic 2009/10 and second year 2010/11a 
Type of influenza-related event
Number of events (%) by age group Chi-square test  
p value0–4 years 5–14 years 15–64 years ≥65 years
Number	of	general	practice	consultations
Pandemic	yeara 61,000	(11) 94,000	(16) 390,000	(67) 34,000	(6)
<0.001
Second	yeara 25,000	(7) 42,000	(11) 280,000	(74) 27,000	(7)
Number	of	hospital	admissions
Pandemic	year 1,790	(27) 1,182	(15) 4,429	(56) 478	(6)
<0.001
Second	year 1,551	(18) 461	(5) 5,797	(66) 988	(11)
Mean	number	of	critical	care	beds	occupiedb
Pandemic	year 7.8	(10) 4.9	(5) 59	(73) 8.7	(11)
0.067
Second	year 15.8	(4) 7.9	(2) 280	(80) 47	(13)
Number	of	deaths
Pandemic	year	(England	only) 22	(6) 35	(10) 240	(66) 64	(18)
0.004
Second	year	(United	Kingdom)c 25	(4) 25	(4) 415	(71) 122	(21)
Population	in	England	(millions) 3.2	(6) 5.9	(11) 34.3	(66) 8.4	(16)
a	 Pandemic	year:	29	June	2009	to	28	February	2010.	Second	year:	4	October	2010	to	27	February	2011.
b	 Counted	at	8	a.m.	on	Wednesdays.
c	 Only	includes	those	for	whom	age	at	death	was	known.
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For	 every	 10,000	 general	 practice	 consultations	 in	
2009/10	there	were	136	hospital	admissions,	29	critical	
care	 admissions	 and	 six	 deaths.	 The	 respective	 num-
bers	 for	 2010/11	 were	 approximately	 twice	 as	 great,	
being	238	hospital	admissions,	59	critical	care	admis-
sions	 and	 13	 deaths.	 In	 contrast,	 measures	 of	 severe	
illness	had	similar	ratios	between	the	two	seasons.	For	
every	1,000	hospital	admissions	in	2009/10	there	were	
215	critical	care	admissions	and	45	deaths.	In	2010/11,	
the	 respective	 numbers	 were	 250	 critical	 care	 admis-
sions	and	53	deaths.
In	the	second	year,	the	younger	age	groups	(0–4	years,	
5–15	years)	were	less	prominently	affected	than	in	the	
pandemic	 year.	 The	 burden	 shifted	 towards	 working-
age	people	(16–64	years)	and	the	elderly	(Table	2,	chi-
square	p<0.001	 for	general	practice	 consultations	and	
hospital	admissions).	This	shift	was	seen	consistently	
across	all	measures	of	influenza	activity.	
Public	 interest	 in	 influenza,	 indicated	 by	 volume	 of	
Internet	 searches,	 showed	 four	 peaks	 of	 activity	
(Figure  3).	 The	 first	 occurred	 in	 April	 2009,	 when	 the	
new	 strain	 of	 the	 virus	 was	 first	 widely	 publicised,	
leading	 to	worldwide	concern	about	an	 imminent	pan-
demic.	 The	 second	 peak	 in	 interest	 occurred	 in	 July	
2009,	coinciding	with	the	first	wave	of	influenza	activ-
ity	 in	 England.	 Two	 further,	 smaller	 peaks	 coincided	
with	the	second	and	third	waves	of	influenza	activity	in	
England.	Public	interest	relative	to	the	burden	of	influ-
enza	 (as	measured	 by	 number	 of	 hospital	 admissions	
per	week)	was	 relatively	high	during	 the	 first	wave	of	
activity,	 lower	during	 the	 second	wave	of	 activity	 and	
very	 low	in	the	third	wave.	Public	 interest	 in	 influenza	
was	four	times	as	great	in	July	2009	as	in	January	2011,	
whereas	the	rate	of	hospital	admission	was	four	times	
as	great	in	January	2011	as	in	July	2009.
During	 the	 pandemic	 year,	 the	 National	 Pandemic	 Flu	
Service	operated	from	23	July	2009	to	11	February	2010.	
It	 dispensed	 1,161,157	 courses	 of	 antiviral	medication	
during	 this	 time.	 Community	 pharmacists	 dispensed	
fewer	 courses:	 10,610	 in	 the	 pandemic	 year	 (June	 to	
February)	 and	 38,692	 in	 the	 second	 year	 (October	 to	
February).	Overall,	 30	 times	more	 courses	 of	 antiviral	
medication	were	dispensed	in	the	pandemic	year	than	
in	the	following	year	(1,171,767	vs	38,692	courses).
Discussion
In	England,	influenza	A(H1N1)pdm09	caused	more	hos-
pital	 admissions,	 more	 critical	 care	 admissions	 and	
more	deaths	in	its	second	year	of	circulation	than	in	the	
pandemic	 year	 itself.	 There	 were	 fewer	 general	 prac-
tice	 consultations	 and	 there	 was	 less	 public	 interest	
in	 influenza	 in	 the	 second	 year	 than	 in	 the	 pandemic	
year.	This	 is	a	worrying	finding	given	that	an	effective	
vaccine	was	available	for	the	duration	of	the	influenza	
season	following	the	pandemic	year.
Ascertainment bias is unlikely
We	 looked	 at	 whether	 systematic	 differences	 in	 the	
methods	 of	 ascertainment	 or	 changes	 to	 the	 defini-
tions	 of	 any	 of	 the	 measures	 analysed	 between	 the	
two	years	could	explain	this	difference.	The	case	defi-
nition	of	 a	death	was	actually	narrower	 in	 the	 second	
year	than	in	the	pandemic	year.	For	hospital	and	critical	
care	 admissions,	 the	 case	 definitions	 and	 ascertain-
ment	methods	were	 the	same	 in	both	years.	However,	
the	system	for	reporting	critical	care	admissions	in	the	
second	 year	was	not	 established	until	mid-December,	
Figure 3
Hospital admissions for influenza and Google searches for ‘flu’, England, 19 January 2009–27 February 2011
Hospital admissions
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after	many	admissions	are	likely	to	have	occurred.	For	
all	these	reasons,	both	deaths	and	critical	care	admis-
sions	 are	 likely	 to	 have	 been	 underestimated	 in	 the	
second	year	relative	to	the	pandemic	year.	It	therefore	
seems	 unlikely	 that	 systematic	 differences	 in	 ascer-
tainment	can	explain	the	principal	finding	of	our	study.
Could	ascertainment	of	deaths,	critical	care	and	hospi-
tal	admissions	have	been	increased	by	enhanced	clini-
cal	 awareness	 of	 influenza,	 leading	 to	 greater	 testing	
for,	 and	 diagnosis	 of,	 the	 disease?	 This	 seems	 highly	
implausible.	 Public	 awareness	 and	 clinical	 awareness	
of	 influenza	 was	 markedly	 lower	 in	 the	 second	 year.	
Why	 would	 England	 be	 alone	 among	 western	 coun-
tries	in	experiencing	a	phenomenon	of	increased	clini-
cal	diagnosis	and	reporting	of	 influenza	in	the	second	
year	relative	to	the	pandemic	year?	No	such	effect	was	
found	 in	 the	 United	 States,	 Canada,	 Australia	 or	 New	
Zealand.	If	anything,	clinical	ascertainment	of	cases	in	
England	is	likely	to	have	been	greater	in	the	pandemic	
year,	when	there	was	huge	media	interest	in	this	novel	
event	 and	 clinicians’	 awareness	 of	 the	 circulation	 of	
the	virus	was	high.	Moreover,	there	was	a	great	deal	of	
communication	between	the	government	and	front-line	
clinicians.	 This	would	 all	 suggest	 that	 the	 true	 differ-
ence	 between	 the	 two	 years	 was	 in	 fact	 greater	 than	
that	reported	here.
The	methods	of	influenza	surveillance	in	general	prac-
tice	in	England	are	long	established	and	unchanged	in	
recent	 years.	 The	 existence	 of	 the	 National	 Pandemic	
Flu	 Service	 from	 July	 2009	 until	 February	 2010	 was	
intended	to	reduce	the	burden	on	general	practice.	No	
equivalent	system	existed	in	the	second	year.	General	
practice	 consultation	 rates	 are	 therefore	 likely	 to	 be	
relatively	 suppressed	 in	 the	 pandemic	 year	 compared	
with	 the	 second.	 Again,	 this	 suggests	 that	 the	 differ-
ence	between	 the	 two	years	 reported	here	 is	a	highly	
conservative	estimate.
Finally,	all	three	measures	of	severe	illness	showed	sim-
ilar	 changes.	We	 have	 also	 heard	 anecdotal	 accounts	
from	 intensive	 care	 physicians	 that	 the	 2010/11	 influ-
enza	season	brought	with	it	serious	cases	of	influenza	
in	previously	healthy	young	individuals	on	a	scale	that	
appeared	 worse	 than	 in	 the	 pandemic	 itself.	 Taken	
together,	 this	 leaves	 little	 room	 for	 doubt	 that	 there	
was	 a	 genuine	 increase	 in	 hospital	 and	 critical	 care	
admissions	and	in	deaths	between	the	two	years.
Most countries did not suffer 
a worse second year
International	 comparisons	 are	 somewhat	 difficult	
because	of	uncertainty	about	the	quality	of	surveillance	
across	 the	 two	 years.	 Those	 comparisons	 that	 can	be	
made	suggest	that	England’s	experience	is	unusual.	In	
the	 second	 year,	 the	United	States	 experienced	 lower	
peak	 ILI	consultations	 (4.6%	vs	7.7%	of	weekly	outpa-
tient	visits),	fewer	paediatric	deaths	(105	vs	282)	and	a	
lower	hospitalisation	rate	(19.1	per	100,000	population	
vs	29.0	per	100,000	population)	 than	in	the	pandemic	
year	 [24].	New	Zealand	 reported	 a	 lower	 peak	 ILI	 rate	
(150	per	100,000	in	2010	vs	275	per	100,000	in	2009),	
fewer	 hospital	 admissions	 (998	 vs	 1,517)	 and	 fewer	
deaths	 (16	 vs	 35)	 [25].	 Similar	 patterns	 were	 seen	 in	
Canada	and	Australia	[26-28].	
The	 European	 picture	 is	 less	 clear	 [29],	 but	 many	
European	countries	have	reported	fewer	cases	of	severe	
illness	 and	 fewer	 deaths	 in	 the	 second	 year	 [30,31].	
Only	 the	 experience	 of	 Ireland,	 Greece	 and	 the	 other	
UK	nations	looks	similar	to	that	of	England.	Ireland	had	
small	 increases	 in	 the	 numbers	 hospitalised,	 treated	
in	 critical	 care	 and	 dying	 [32,33].	 Greece	 experienced	
more	 intensive	care	admissions	and	 fatal	cases	 in	 the	
post-pandemic	 season	 than	 in	 the	 pandemic	 season	
(368	vs	294	and	180	vs	149	respectively),	although	the	
magnitude	 was	 not	 on	 the	 same	 scale	 as	 in	 England	
[34].	Broadly,	the	English	pattern	was	replicated	in	the	
other	UK	nations,	with	higher	peak	 levels	of	 influenza	
activity	 in	2010/11	and	similar	or	slightly	more	deaths	
(69	 deaths	 in	 Scotland	 in	 2009/10	 vs	 63	 in	 2010/11,	
Wales	28	vs	34,	Northern	Ireland	18	vs	31)	[9,21].
Government response was the major 
difference between the two years
What	 could	 explain	 the	 greater	 burden	 of	 severe	 ill-
ness	 in	 the	 second	 year?	 The	 virus	 has	 been	 closely	
observed.	 Its	 genetic	 composition	 had	 not	 changed	
[21].	 Influenza	B	virus	was	more	evident	in	the	second	
year	 than	 in	 the	 pandemic	 year.	 It	 was	 the	 causative	
agent	 detected	 in	 24.1%	 of	 positive	 influenza	 speci-
mens	 (compared	with	 just	0.3%	 in	 the	pandemic	year)	
but	accounted	for	just	6.6%	of	deaths	[21].	There	were	
anecdotal	reports	of	serious	illness	caused	by	coinfec-
tion	 in	 the	second	year,	but	 the	 total	number	of	 these	
reports	 is	 not	 great	 [2,35,36].	While	 the	 small	 shift	 in	
age	 distribution	 towards	 older	 age	 groups,	 who	 are	
more	 prone	 to	 the	 severe	 effects	 of	 influenza,	 will	
have	 contributed	 to	 the	 greater	 burden	 of	 severe	 ill-
ness	[34],	similar	shifts	have	been	seen	elsewhere	but	
not	resulted	in	a	greater	burden	of	severe	 illness	[28].	
Peak	transmission	in	the	second	year	occurred	later	in	
the	year,	when	the	weather	in	England	was	colder	and	
drier.	 This	may	 have	 had	 a	 role	 in	 facilitating	 greater	
transmission	of	the	virus	in	the	second	year	[37-39].
However,	 the	 most	 notable	 difference	 between	 the	
two	 years	 was	 the	 government	 response.	 The	 pub-
lic	 health	 response	 in	 the	 pandemic	 year	 was	 highly	
assertive.	Strong	public	awareness	and	education	cam-
paigns	were	run.	Extensive	and	rolling	media	coverage	
throughout	 the	 duration	 of	 the	 emergency	 is	 likely	 to	
have	 enhanced	 public	 understanding.	 Antiviral	 drugs	
were	 widely	 used	 for	 symptomatic	 individuals	 and	 (in	
the	 early	 phase)	 their	 contacts.	 Schools	 were	 closed,	
with	 antiviral	 treatment	 of	 cases	 and	 contacts.	 Unlike	
previous	 influenza	 pandemics,	 a	 vaccine	 was	 made	
available	and	used	before	the	end	of	the	pandemic	year.	
In	 contrast,	 in	 the	 influenza	 season	 that	 followed	 the	
pandemic	 year,	 the	 approach	 was	 laissez-faire.	 The	
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superimposed	bacterial	 illness	or	 other	 severe	 illness	
may	have	been	delayed.	
Predictable age distribution: younger than 
those with typical seasonal influenza
Both	years	saw	a	high	ratio	of	young	to	elderly	influenza	
deaths	in	comparison	with	that	seen	in	a	typical	influ-
enza	season.	 The	second	year	 saw	a	small	 shift	 away	
from	 the	 younger	 age	 groups	 towards	 adults	 of	work-
ing	 age.	 This	 is	 consistent	with	past	 influenza	behav-
iour.	Analysing	historical	influenza	mortality	data	from	
the	United	States,	Simonsen	et	 al.	 have	 shown	 that	 a	
marked	shift	 in	mortality	away	 from	the	elderly	 to	 the	
young	 has	 occurred	 in	 the	 first	 year	 of	 previous	 pan-
demics	 [53].	 This	 shift	 persists,	 slowly	 drifting	 back	
towards	 the	 elderly	 over	 a	 period	 of	 10	 to	 20	 years.	
Influenza	 A(H1N1)pdm09	 is	 so	 far	 behaving	 similarly.	
This	shows	the	 importance	not	only	of	 remaining	vigi-
lant	after	 the	 first	passing	of	 the	pandemic	wave,	but	
also	 of	 maintaining	 heightened	 vigilance	 for	 several	
years	after.
Conclusion
England	experienced	a	greater	burden	of	severe	illness	
due	 to	 influenza	 A(H1N1)pdm09	 in	 the	 second	 year	 of	
its	circulation	than	in	the	pandemic	year.	The	difference	
appears	 to	 be	 real	 rather	 than	 fallacious.	By	 the	 time	
of	the	second	influenza	season,	much	had	been	learnt	
about	 the	 potential	 impact	 of	 the	 virus	 and	 an	 effec-
tive	vaccine	developed.	Despite	this,	a	large	number	of	
deaths,	critical	care	and	hospital	admissions	occurred,	
many	of	 these	 in	otherwise	healthy	people	of	working	
age.	The	differences	 in	 the	government	 response	over	
the	two	years	were	striking	and	likely	to	have	contrib-
uted	to	the	increased	impact	of	the	disease	in	the	sec-
ond	year.
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